Actinic Keratosis Study

Completed · Early Phase 1

Conditions studied: Actinic Keratosis

In brief

The main purpose of this study is to determine the effectiveness of a new combination therapy for actinic keratosis. This study investigates a new indication for an FDA-approved topical medication, calcipotriol, for treatment of actinic keratosis, including how well it works and how safe it is when used in combination with the standard of care medication (5-fluorouracil) for the skin condition.

Key facts

Study ID
NCT02019355
Run by
Washington University School of Medicine
People needed
132
Starts
2013-10-01
Expected to finish
2015-03-01
Last updated by the study team
2016-05-19

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.